Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Buller

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
Molecular Genetics and Metabolism|August 13, 1999
BRCA1 mutations in familial ovarian cancerT A Lallas, T E Buekers, R E Buller
Gynecologic Oncology|August 12, 1998
A novel technique for gynecologic oncology surgery in the presence of abdominal wall mesh prosthesisT E Buekers, J I Sorosky, R E Buller
The Journal of Biological Chemistry|February 10, 1975
Progesterone-binding components of chick oviduct. IX. The kinetics of nuclear bindingR E Buller, W T Schrader, B W O'Malley
Gynecologic Oncology|July 1, 1995
Comparison of a novel redox dye cell growth assay to the ATP bioluminescence assayR C Squatrito, J P Connor, R E Buller
Biochemical and Biophysical Research Communications|March 8, 1976
Steroid hormone receptor fraction stimulation of RNA synthesis: a cautionR E Buller, R J Schwartz, B W O'Malley
Journal of Steroid Biochemistry|May 1, 1976
Steroids and the practical aspects of performing binding studiesR E Buller, W T Schrader, B W O'Maller
Cancer Research|March 15, 1997
Ovarian cancer genomic instability correlates with p53 frameshift mutationsA K Sood, J S Skilling, R E Buller
Gynecologic Oncology|November 1, 1993
Familial ovarian cancerR E Buller, B Anderson, J P Connor, et al.
Cancer Research|June 5, 2001
Application of the National Cancer Institute international criteria for determination of microsatellite instability in ovarian cancerA K Sood, R Holmes, M J Hendrix, et al.
Gynecologic Oncology|March 1, 1995
Steroid hormone receptor content and lymph node status in endometrial cancerP C Morris, J R Anderson, B Anderson, et al.
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Molecular Genetics and Metabolism|August 13, 1999
BRCA1 mutations in familial ovarian cancerT A Lallas, T E Buekers, R E Buller
Gynecologic Oncology|August 12, 1998
A novel technique for gynecologic oncology surgery in the presence of abdominal wall mesh prosthesisT E Buekers, J I Sorosky, R E Buller
The Journal of Biological Chemistry|February 10, 1975
Progesterone-binding components of chick oviduct. IX. The kinetics of nuclear bindingR E Buller, W T Schrader, B W O'Malley
Gynecologic Oncology|July 1, 1995
Comparison of a novel redox dye cell growth assay to the ATP bioluminescence assayR C Squatrito, J P Connor, R E Buller
Biochemical and Biophysical Research Communications|March 8, 1976
Steroid hormone receptor fraction stimulation of RNA synthesis: a cautionR E Buller, R J Schwartz, B W O'Malley
Journal of Steroid Biochemistry|May 1, 1976
Steroids and the practical aspects of performing binding studiesR E Buller, W T Schrader, B W O'Maller
Cancer Research|March 15, 1997
Ovarian cancer genomic instability correlates with p53 frameshift mutationsA K Sood, J S Skilling, R E Buller
Gynecologic Oncology|November 1, 1993
Familial ovarian cancerR E Buller, B Anderson, J P Connor, et al.
Cancer Research|June 5, 2001
Application of the National Cancer Institute international criteria for determination of microsatellite instability in ovarian cancerA K Sood, R Holmes, M J Hendrix, et al.
Gynecologic Oncology|March 1, 1995
Steroid hormone receptor content and lymph node status in endometrial cancerP C Morris, J R Anderson, B Anderson, et al.
Pageof 10